Apogee Therapeutics, Inc. Deferred Tax Liabilities, Gross
Apogee Therapeutics, Inc. (APGE) had Deferred Tax Liabilities, Gross of $2.02 million as of 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-03-02
- 2025-12-31: Deferred Tax Liabilities, Gross $2.02M.
- 2024-12-31: Deferred Tax Liabilities, Gross $2.75M.
- 2023-12-31: Deferred Tax Liabilities, Gross $574.00K.
| Period end | Deferred Tax Liabilities, Gross |
|---|---|
| 2025-12-31 | $2.02M 10-K · filed 2026-03-02 |
| 2024-12-31 | $2.75M 10-K · filed 2026-03-02 |
| 2023-12-31 | $574.00K 10-K · filed 2026-03-02 |